Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 712617, 7 pages
http://dx.doi.org/10.1155/2012/712617
Clinical Study

The Common C49620T Polymorphism in the Sulfonylurea Receptor Gene SUR1 (ABCC8) in Patients with Gestational Diabetes and Subsequent Glucose Metabolism Abnormalities

1Department of Diabetology and Internal Diseases, Pomeranian Medical University, Szczecin, Poland
2Chair of Clinical Biochemistry and Laboratory Diagnostics, Pomeranian Medical University, Szczecin, Poland
3Chair of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland
4Department of Maternal-Fetal Medicine and Gynecology, Pomeranian Medical University, Szczecin, Poland
5Department of Endocrinology, Metabolic and Internal Diseases, Pomeranian Medical University, Szczecin, Poland

Received 5 February 2012; Accepted 9 July 2012

Academic Editor: Asli F. Ceylan-Isik

Copyright © 2012 Piotr Molęda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
  2. T. A. Buchanan and A. H. Xiang, “Gestational diabetes mellitus,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 485–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Ferrara, “Increasing prevalence of gestational diabetes mellitus: a public health perspective,” Diabetes Care, vol. 30, supplement 2, pp. S141–S146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Feig, B. Zinman, X. Wang, and J. E. Hux, “Risk of development of diabetes mellitus after diagnosis of gestational diabetes,” Canadian Medical Association Journal, vol. 179, no. 3, pp. 229–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Zonenberg, B. Telejko, J. Topolska et al., “Factors predisposing to disturbed carbohydrate tolerance in patients with previous gestational diabetes mellitus,” Diabetologia Doswiadczalna i Kliniczna, vol. 6, no. 3, pp. 143–150, 2006. View at Google Scholar · View at Scopus
  6. K. Baptiste-Roberts, B. B. Barone, T. L. Gary et al., “Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review,” American Journal of Medicine, vol. 122, no. 3, pp. 207–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Bellamy, J. P. Casas, A. D. Hingorani, and D. Williams, “Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis,” The Lancet, vol. 373, no. 9677, pp. 1773–1779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Lauenborg, T. Hansen, D. M. Jensen et al., “Increasing incidence of diabetes after gestational diabetes,” Diabetes Care, vol. 27, no. 5, pp. 1194–1199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. A. Buchanan, B. E. Metzger, N. Freinkel, and R. N. Bergman, “Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes,” American Journal of Obstetrics and Gynecology, vol. 162, no. 4, pp. 1008–1014, 1990. View at Google Scholar · View at Scopus
  10. T. A. Buchanan, “Pancreatic B-cell defects in gestational diabetes: Implications for the pathogenesis and prevention of type 2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 3, pp. 989–993, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. W. P. Pimenta, I. M. P. Calderon, N. S. Cruz, M. L. Santos, F. F. Aragon, and C. R. Padovani, “Subclinical abnormalities of glucose metabolism in Brazilian women with a history of gestational diabetes mellitus,” Acta Obstetricia et Gynecologica Scandinavica, vol. 83, no. 12, pp. 1152–1158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Kousta, N. J. Lawrence, I. F. Godsland et al., “Early metabolic defects following gestational diabetes in three ethnic groups of anti-GAD antibodies negative women with normal fasting glucose,” Hormones, vol. 6, no. 2, pp. 138–147, 2007. View at Google Scholar · View at Scopus
  13. Y. M. Cho, T. H. Kim, S. Lim et al., “Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population,” Diabetologia, vol. 52, no. 2, pp. 253–261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. M. Thomas, G. J. Cote, N. Wohllk et al., “Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy,” Science, vol. 268, no. 5209, pp. 426–429, 1995. View at Google Scholar · View at Scopus
  15. E. H. Hani, K. Clément, G. Velho et al., “Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians,” Diabetes, vol. 46, no. 4, pp. 688–694, 1997. View at Google Scholar · View at Scopus
  16. L. M. Hart, P. De Knijff, J. M. Dekker et al., “Variants in the sulphonylurea receptor gene: Association of the exon 16- 3t variant with Type II diabetes mellitus in Dutch Caucasians,” Diabetologia, vol. 42, no. 5, pp. 617–620, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Rissanen, A. Markkanen, P. Kärkkäinen et al., “Sulfonylurea receptor I gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin,” Diabetes Care, vol. 23, no. 1, pp. 70–73, 2000. View at Google Scholar · View at Scopus
  18. G. Mancia, G. De Backer, A. Dominiczak et al., “2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” Journal of Hypertension, vol. 25, no. 6, pp. 1105–1187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. http://www.dtu.ox.ac.uk/index.php?maindoc=/homa/index.php.
  20. A. Stefanski, L. Majkowska, A. Ciechanowicz et al., “The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 115, no. 5, pp. 317–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Kim, K. M. Newton, and R. H. Knopp, “Gestational diabetes and the incidence of type 2 diabetes: a systematic review,” Diabetes Care, vol. 25, no. 10, pp. 1862–1868, 2002. View at Google Scholar · View at Scopus
  22. H. Inoue, J. Ferrer, C. M. Welling et al., “Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians,” Diabetes, vol. 45, no. 6, pp. 825–831, 1996. View at Google Scholar · View at Scopus
  23. O. Laukkanen, J. Pihlajamäki, J. Lindström et al., “Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention study,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6286–6290, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Watanabe, M. H. Black, A. H. Xiang, H. Allayee, J. M. Lawrence, and T. A. Buchanan, “Genetics of gestational diabetes mellitus and type 2 diabetes,” Diabetes Care, vol. 30, no. 2, pp. S134–S140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Dorner, A. Plagemann, and H. Reinagel, “Familial diabetes aggregation in type I diabetics: Gestational diabetes an apparent risk factor for increased diabetes susceptibility in the offspring,” Experimental and Clinical Endocrinology, vol. 89, no. 1, pp. 84–90, 1987. View at Google Scholar · View at Scopus
  26. J. A. S. McLellan, B. A. Barrow, J. C. Levy et al., “Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes,” Diabetologia, vol. 38, no. 6, pp. 693–698, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. P. J. Saker, A. T. Hattersley, B. Barrow et al., “High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population,” Diabetologia, vol. 39, no. 11, pp. 1325–1328, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Ellard, F. Beards, L. I. S. Allen et al., “A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria,” Diabetologia, vol. 43, no. 2, pp. 250–253, 2000. View at Google Scholar · View at Scopus
  29. R. M. Watanabe, A. H. Xiang, and H. Allayee, “Evidence of genetic predisposition for B-cell dysfunction in Mexican-American families of probands with gestational diabetes (Abstract),” Diabetes, vol. 52, supplement 1, p. A257, 2003. View at Google Scholar
  30. J. Lauenborg, N. Grarup, P. Damm et al., “Common type 2 diabetes risk gene variants associate with gestational diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 145–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. X. M. Niu, H. Yang, H. Y. Zhang et al., “Study on association between gestational diabetes mellitus and sulfonylurea receptor-1 gene polymorphism,” Zhonghua Fu Chan Ke Za Zhi, vol. 40, no. 3, pp. 159–163, 2005. View at Google Scholar · View at Scopus
  32. S. Ackermann, S. Hiller, H. Osswald, M. Lösle, A. Grenz, and A. Hambrock, “17β-estradiol modulates apoptosis in pancreatic β-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1,” Journal of Biological Chemistry, vol. 284, no. 8, pp. 4905–4913, 2009. View at Publisher · View at Google Scholar · View at Scopus